SSRI treatment suppresses dream recall frequency but increases subjective dream intensity in normal subjects.
Journal of Sleep Research June 1, 2001 E F Pace-Schott, T Gersh, R Silvestri et al.
Clinical lore and a small number of published studies report that the selective serotonin reuptake inhibitors (SSRIs) intensify dreaming. This study examines the dream effects of paroxetine and fluvoxamine in order to both increase clinical knowledge of these agents and to test an important potential method for probing the relationship between REM sleep neurobiology and dreaming in humans....